|
ZNF493 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29710000518202E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.4128999998041E-07 |
| Normal-vs-Stage2 |
1.236750E-01 |
| Normal-vs-Stage3 |
5.98239999982653E-07 |
| Normal-vs-Stage4 |
2.29180000532736E-08 |
| Stage1-vs-Stage2 |
3.644000E-01 |
| Stage1-vs-Stage3 |
5.222200E-01 |
| Stage1-vs-Stage4 |
7.960000E-02 |
| Stage2-vs-Stage3 |
2.417200E-01 |
| Stage2-vs-Stage4 |
7.850100E-02 |
| Stage3-vs-Stage4 |
2.871000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17599999632989E-08 |
| Normal-vs-AfricanAmerican |
2.35669999959498E-07 |
| Normal-vs-Asian |
1.509630E-01 |
| Caucasian-vs-AfricanAmerican |
3.038800E-01 |
| Caucasian-vs-Asian |
6.331600E-01 |
| AfricanAmerican-vs-Asian |
2.700600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.10649994617052E-09 |
| Normal-vs-Female |
4.32850000000595E-05 |
| Male-vs-Female |
6.792200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.037260E-03 |
| Normal-vs-Age(41-60Yrs) |
3.59600000000571E-05 |
| Normal-vs-Age(61-80Yrs) |
2.80220002757403E-09 |
| Normal-vs-Age(81-100Yrs) |
1.037950E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.030000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.344800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.600800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.908500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.501000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.273000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.025800E-02 |
| Normal-vs-Grade 2 |
8.2773000000036E-05 |
| Normal-vs-Grade 3 |
6.23819995659858E-09 |
| Normal-vs-Grade 4 |
1.36719999765944E-08 |
| Grade 1-vs-Grade 2 |
9.692600E-01 |
| Grade 1-vs-Grade 3 |
4.311200E-01 |
| Grade 1-vs-Grade 4 |
1.500400E-01 |
| Grade 2-vs-Grade 3 |
5.171600E-02 |
| Grade 2-vs-Grade 4 |
4.956000E-03 |
| Grade 3-vs-Grade 4 |
9.764200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.015360E-04 |
| Normal-vs-ccB subtype |
1.82978999999639E-05 |
| ccA subtype-vs-ccB subtype |
3.022600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.89249999999119E-06 |
| Normal-vs-N1 |
1.5959600000004E-05 |
| N0-vs-N1 |
3.465600E-02 |
|
|
